Press release
Advanced Ovarian Cancer Pipeline Landscape Analysis: 50+ Key Players & 50+ Pipeline Drugs
In the Advanced Ovarian Cancer Pipeline Insight report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Advanced Ovarian Cancer collaborations, licensing, mergers and acquisition, funding, designations and other product related details.
Key takeaways from the Advanced Ovarian Cancer Pipeline Insight Report
• DelveInsight's Advanced Ovarian Cancer Pipeline analysis depicts a robust space with 50+ active players working to develop 50+ pipeline treatment therapies.
• The leading Advanced Ovarian Cancer Companies are working such as ImmunoGen, OncoQuest, Lee's Pharmaceutical, Allarity Therapeutics, AstraZeneca, Jiangxi Qingfeng Pharmaceutical Co. Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Ellipses Pharma, Merck KGaA, Pfizer, Jiangsu HengRui Medicine Co., Ltd., Boehringer Ingelheim, Impact Therapeutics Inc., Glycotope, Puma Biotechnology, Inc, MaxCyte, Inc., Bayer, Xennials Therapeutics, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Daiichi Sankyo, Inc., Astellas Pharma Inc, and others.
• Promising Advanced Ovarian Cancer Pipeline therapies such as Neoadjuvant chemotherapy, M-Trap, MM-121, Paclitaxel, AVE0005, AGS-8M4, Trabectedin, Dexamethasone, IMAB027, Niraparib, and Others.
• The Advanced Ovarian Cancer companies and academics are working to assess challenges and seek opportunities that could influence Advanced Ovarian Cancer R&D. The therapies under development are focused on novel approaches to treat/improve Advanced Ovarian Cancer.
Recent Developmental Activities in the Advanced Ovarian Cancer Pipeline
• OncoQuest's lead product candidate is oregovomab, an anti-CA-125 antibody, for the treatment of ovarian cancer that has completed a Phase 2 frontline randomized controlled study. The company is conducting a Phase 3, Double-Blind, Placebo-Controlled, Multicenter Clinical Study comparing Chemo-Immunotherapy (Paclitaxel - Carboplatin - Oregovomab) versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) In Patients with Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma (FLORA-5/GOG-3035).
• The US Food and Drug Administration (FDA) granted orphan drug designation to mirvetuximab for the treatment of ovarian cancer; mirvetuximab has also received this designation in the EU. In June 2018, the FDA granted mirvetuximab Fast Track designation for the treatment of patients with medium to high FRα-positive platinum-resistant ovarian cancer who received at least one, but no more than three prior systemic treatment regimens, and for whom single-agent chemotherapy is appropriate as the next line of therapy. This designation is intended to facilitate the development and expedite the review of drugs to treat serious and life-threatening conditions.
Request a sample and discover the recent advances in Advanced Ovarian Cancer Clinical Trials Analysis @ https://www.delveinsight.com/sample-request/advanced-liver-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Advanced Ovarian Cancer Overview
Advanced Ovarian Cancer means that the cancer has spread outside. It may have spread within the pelvis or abdomen, or further away to other parts of the body such as the lungs. Some women have Advanced Ovarian Cancer when they are first diagnosed, and treatment can cure their cancer. This depends on several factors, including the exact stage of the cancer. Chemotherapy, surgery and targeted cancer drugs are all treatments for Advanced Ovarian Cancer. Some women may have radiotherapy. Targeted cancer drugs can help the body to control the growth of cancer cells. Occasionally doctors suggest radiotherapy for Advanced Ovarian Cancer. Radiotherapy can shrink tumours and reduce symptoms.
Advanced Ovarian Cancer Emerging Drugs
• Mirvetuximab soravtansine (IMGN853): ImmunoGen
• Oregovomab: OncoQuest
Advanced Ovarian Cancer Pipeline Therapeutics Analysis
There are approx. 50+ key companies which are developing the therapies for Advanced Ovarian Cancer. The companies which have their Advanced Ovarian Cancer drug candidates in the most advanced stage, i.e. phase III include, ImmunoGen.
Learn more about the emerging Advanced Ovarian Cancer Treatment Landscape @ https://www.delveinsight.com/sample-request/advanced-liver-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Advanced Ovarian Cancer Pipeline Report
• Coverage- Global
• Advanced Ovarian Cancer Assessment by Product Type
• Advanced Ovarian Cancer Assessment by Stage and Product Type
• Advanced Ovarian Cancer Assessment by Route of Administration
• Advanced Ovarian Cancer Assessment by Stage and Route of Administration
• Advanced Ovarian Cancer Assessment by Molecule Type
• Advanced Ovarian Cancer Assessment by Stage and Molecule Type
• Advanced Ovarian Cancer Companies- ImmunoGen, OncoQuest, Lee's Pharmaceutical, Allarity Therapeutics, AstraZeneca, Jiangxi Qingfeng Pharmaceutical Co. Ltd., CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Ellipses Pharma, Merck KGaA, Pfizer, Jiangsu HengRui Medicine Co., Ltd., Boehringer Ingelheim, Impact Therapeutics Inc., Glycotope, Puma Biotechnology, Inc, MaxCyte, Inc., Bayer, Xennials Therapeutics, Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Daiichi Sankyo, Inc., Astellas Pharma Inc, and others.
• Advanced Ovarian Cancer Pipeline Therapies- Neoadjuvant chemotherapy, M-Trap, MM-121, Paclitaxel, AVE0005, AGS-8M4, Trabectedin, Dexamethasone, IMAB027, Niraparib, and Others.
Table of Content
1. Introduction
2. Executive Summary
3. Advanced Ovarian Cancer: Overview
4. Pipeline Therapeutics
5. Therapeutic Assessment
6. Late Stage Products (Phase III)
7. Mirvetuximab soravtansine (IMGN853): ImmunoGen
8. Drug profiles in the detailed report…..
9. Mid Stage Products (Phase II)
10. EP0057: Ellipses Pharma
11. Drug profiles in the detailed report…..
12. Early Stage Products (Phase I)
13. DS-6000a: Daiichi Sankyo Company
14. Drug profiles in the detailed report…..
15. Preclinical and Discovery Stage Products
16. Drug name: Company name
17. Drug profiles in the detailed report…..
18. Inactive Products
19. Advanced Ovarian Cancer Key Companies
20. Advanced Ovarian Cancer Key Products
21. Advanced Ovarian Cancer- Unmet Needs
22. Advanced Ovarian Cancer- Market Drivers and Barriers
23. Advanced Ovarian Cancer- Future Perspectives and Conclusion
24. Advanced Ovarian Cancer Analyst Views
25. Advanced Ovarian Cancer Key Companies
26. Appendix
Key Questions
Current Treatment Scenario and Emerging Therapies:
• How many companies are developing Advanced Ovarian Cancer drugs?
• How many Advanced Ovarian Cancer drugs are developed by each company?
• How many emerging drugs are in mid-stage, and late-stage of development for the treatment of Advanced Ovarian Cancer?
• What are the key collaborations (Industry-Industry, Industry-Academia), Mergers and acquisitions, licensing activities related to the Advanced Ovarian Cancer therapeutics?
• What are the recent trends, drug types and novel technologies developed to overcome the limitation of existing therapies?
• What are the clinical studies going on for Advanced Ovarian Cancer and their status?
• What are the key designations that have been granted to the emerging drugs?
Got Queries? Reach out to us for Advanced Ovarian Cancer Pipeline Drugs Report related information @ https://www.delveinsight.com/report-store/advanced-ovarian-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: ybhardwaj@delveinsight.com
Phone: 9193216187
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advanced Ovarian Cancer Pipeline Landscape Analysis: 50+ Key Players & 50+ Pipeline Drugs here
News-ID: 2812422 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Advanced
Advanced Oxidation Technologies Market Size, Share 2021, Impressive Industry Gro …
The Advanced Oxidation Technologies Market is poised to take off in upcoming years hence showing a highly positive outlook through 2020-2028, according to a recently released report. Advanced Oxidation Technologies Market report covers industry chain analysis, latest market trends & dynamics along with cost profit analysis of major key players which focuses on expansion rate, prices, competition, size, prices, and value chain analysis of those leaders in the market.
The…
Medical Ceramics Market Analysis and Industry Forecast | Advanced Ceramics Resea …
Allied Market Research published a new report, titled, “Medical Ceramics Market by Type (Aluminum Oxide, Zirconia, and Carbon, Hydroxyapatite, Glass & Bioglass, Zirconia Alumina, Bioresorbable Ceramics, and Piezo Ceramics), by Application (Surgical Instruments, Diagnostic Equipment, Orthopedic Implants, Electronic Implants, Dental Implants, Disposables, and Packaging) – Global Opportunity Analysis and Industry Forecast, 2014 – 2022.” The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter’s Five…
Skincell Advanced Reviews – Does Skincell Advanced Really Work?
People want clear, blemish-free skin! However, most people have skin tags, moles, and warts. Some causes are known, while some blemishes are caused without any reason at all. When a regular skincare regimen fails, people turn to costly surgeries and medications. Cleansing and moisturizing might not work well for all. All skin types are not the same, and toners and skincare creams seldom give long-lasting benefits.
Get Skincell Advanced From Its…
Global Advanced Oxidation Technologies Market 2019- 2025 || A-Zone Technologies, …
Synopsis of the Advanced Oxidation Technologies Market:
Latest Report on Advanced Oxidation Technologies Market deliberates the effect of various Factors influencing the market growth and drivers. Its further sheds light on market overview, key manufacturers, strategic adopted by them, size, latest trends and types, revenue, gross margin with regional analysis and forecast to 2025.
Overview of the Advanced Oxidation Technologies Market Report:
Advanced Oxidation Technologies Market report includes knowledge about the market overview…
Global Advanced Materials Market - 3M Company, DowDuPont Inc, Hexcel Corporation …
A New fresh research report presented by KD Market Insights provides a detailed analysis of “Advanced Materials Market - By Product type (Structural Material, Functional Material, Emerging Material) By End User (Building & Construction, Automotive, Aerospace, Defense, Marine, Electrical & Electronics, Healthcare, Oil & Gas and Energy, Others) & Global Region - Market Size, Trends, Share and Forecast 2018-2023” research report will include all the major trends and technologies that…
Global Advanced Materials Market: 3M Company, DowDuPont Inc, Hexcel Corporation, …
A New fresh research report presented by KD Market Insights provides a detailed analysis of “Advanced Materials Market 2017: Market Size, Trends & Opportunity Outlook – Forecast to 2023” research report will include all the major trends and technologies that play an important role in market growth in the predicted span of 6 years. It also presents the overview of industry players, advantages, challenges the business is going through. The…
